http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0001318-A2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate | 1998-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79ee475e0dbf59be091441c92767996a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9629eeb0dab4a791e96b8d35c625914e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3d5d26ed3738f91ad7d0916d1b53f6b |
| publicationDate | 2000-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-0001318-A2 |
| titleOfInvention | Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and their use as therapeutic agents |
| abstract | The present invention relates to a refractory cytoplasmic region that specifically binds to cold CD23 and binds coolly to gamma-gameplay, FC-gamma-primer, and, in particular, to lymph gamma-1 lymph node lymphocytes that inhibit IgE expression. A further object of the present invention is to provide said pharmaceuticals for use in the manufacture of a pharmaceutical composition and to include antibodies for the treatment or prophylaxis of allergic conditions, diseases of the mammary gland, and obstructive diseases. ŕ |
| priorityDate | 1998-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 379.